Company: GEHC
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001628280-25-017240
Chunk: 33

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 33
---
Us granted by the closing market price of a share of GE HealthCare common stock on the date of grant. Stock awards outstanding as of December 31, 2024 for each non-employee director consisted of 2,440 RSUs.

(3) On May 21, 2024, Mr. Hochman and Ms. Madden each received a grant of 1,525 DSUs in lieu of their annual cash retainer. The grant date fair value of each award was $124,959, determined as noted in footnote 2 above.

(4) On May 21, 2024, Mr. Stromberg received a grant of 1,769 DSUs in lieu of his annual cash retainer. The grant date fair value of that award was $144,952, determined as noted in footnote 2 above.

#### GE HEALTHCARE 2025 PROXY STATEMENT35

#### Compensation
| Management Proposal No. 2                                                  
 Approval of Our Named Executive Officers’ Compensation in an Advisory Vote |     |                                                         |     | What are you voting on?                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
 Pursuant to Section 14A of the Exchange Act, we are asking stockholders to approve, on an advisory basis, the compensation paid to our NEOs in 2024, as described in this proxy statement.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
 We currently hold say-on-pay votes annually. The next say-on-pay vote will occur at our 2026 Annual Meeting of Stockholders.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
 Why the Board recommends a vote FOR the say-on-pay proposal?                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
 As described in the Compensation Discussion and Analysis below, the Board believes our executive compensation program is designed to effectively align the interests of our executives, including our NEOs, with our stockholders. The Company’s compensation programs play a significant role in our ability to attract, retain, and motivate top talent to enable our strategies to create a world where healthcare has no limits. Furthermore, the Board believes the use of a mix of base salary and annual and long-term incentives, along with performance metrics tied to executing on our business strategies and priorities, will result in long-term value creation. 
 Accordingly, the Board recommends that stockholders vote FOR the following resolution:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
 “RESOLVED, that the compensation of the Company’s named executive officers, as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including the Compensation Discussion and Analysis, compensation tables, and related information provided in this